Can-Fite Partners, Univo Pharmaceuticals Join Forces On Medical Cannabis-Based Therapeutics

Biotechnology company Can-Fite BioPharma Ltd. CANF announced Tuesday it has partnered with the medical cannabis company Univo Pharmaceuticals to work on developing cannabinoid-based pharmaceuticals for treating cancer, autoimmune, metabolic and inflammatory diseases.

The agreement has two main provisions: 

  • Can-Fite and Univo will work together on the discovery, development and commercialization of medical cannabis-based therapeutics, with Can-Fite having a first right to ask for clinical development of those cannabis components. 
  • Can-Fite will work on creating a screening assay for recognizing therapeutically active cannabis components, and Univo shall promote the assay to other pharmaceutical companies across the world.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Per the agreement, Univo will supply Can-Fite with cannabis components and allow it to use its laboratories for research and production.

Meanwhile, Can-Fite will pay Univo $500,000 in two installments and it will issue to Univo around 19.9 million of its ordinary shares through a private placement.  

Revenues obtained from the partnership will be fairly shared between the two companies based on each party’s contribution.

“Can-Fite’s deep expertise in A3 adenosine receptors is a significant asset in our joint collaboration and we are pleased to have formed this alliance,” Univo CEO Golan Bitton said in a statement.

“Can-Fite has taken its drug candidates into Phase II and Phase III clinical studies and this makes Can-Fite highly suitable to take cannabis-based therapeutics into fully fledged clinical development.”

Can-Fite shares were rallying by 10.88% at $2.65 at the time of publication Tuesday. 

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter

Posted In: marijuanapotUnivo PharmaceuticalsweedCannabisNewsContractsMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.